« Return to News | CROs/Service Providers

Phase Forward Founder Steps Down

Thursday, October 9, 2008 01:00 PM

Dr. Paul Bleicher, chairman and founder of Waltham, Mass.-based eClinical technology company Phase Forward, will step down from his day-to-day operational responsibilities at the end of October. Phase Forward president and CEO Robert Weiler will also assume Bleicher’s role as chairman of the company’s board of directors, of which Bleicher will remain a member.

Other personnel news from the clinical trials industry:

Oncology contract research organization (CRO) Medelis, based in Phoenix, Ariz., named Deirdre Tessman managing director of Medelis Europe, the company’s new European division. Formerly of Tessman Technology and ILEX Pharmaceuticals, Tessman has directed all phases of pharmaceutical development from research through drug approval and marketing with additional expertise in the startup and turnaround of pharmaceutical companies.

Wilmington, Mass.-based Charles River Laboratories appointed Christophe Berthoux to the newly created position of executive vice president, global sales and marketing, and chief commercial officer. The goal of Charles River’s new global sales and marketing organization is to enhance the company’s ability to provide customers with a centralized, integrated approach to their drug development programs.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.